Skip to content
Study details
Enrolling now

HIV+ Deceased Donor Heart Transplant Study for HIV+ Recipients

University of Texas Southwestern Medical Center
NCT IDNCT06659952ClinicalTrials.gov data as of Apr 2026
Target enrollment

50

Study length

about 10 years

Ages

18+

Locations

1 site in TX

What this study is about

Researchers are testing whether heart organ transplantation from HIV+ deceased donors is as safe and effective in HIV+ recipients as transplants from HIV- deceased donors. The trial is comparing the outcomes of HIV-positive heart transplant recipients by the HIV status of the donor; HIV-positive vs. HIV-negative, to learn if this type of transplant is safe and effective for HIV+ patients.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.HIV-positive heart transplant

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Standard

How treatment is administered

Treatment Assignment
Randomized (Open Label)

You are randomly assigned, but you will know your treatment.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Endpoints

Secondary: Number of Participants With One or More Serious Adverse Experience (SAE)

Body systems

Cardiology / Heart, Immune, Infectious